Trial · NCT07892131
Effects of Progressive Neck Motor Control Exercises With and Without Conventional Therapy in Text Neck Syndrome.(PNMCE-TNS)
NCT07892131, Not applicable, Not yet recruiting, University of Management and Technology Lahore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Progressive Neck Motor Control Exercises With and Without Conventional Therapy in Text Neck Syndrome.(PNMCE-TNS). Trials, record NCT07892131. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892131
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Progressive Neck Motor Control Exercises With and Without Conventional Therapy in Text Neck Syndrome.(PNMCE-TNS)
- NCT number
- NCT07892131
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 44 participants, estimated
- Lead sponsor
- University of Management and Technology Lahore
- Conditions
- Text Neck Syndrome
- Interventions
- Progressive Neck Motor Control Exercises, Progressive Neck Motor Control Exercises and Conventional Therapy
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | NUMERICAL PAIN RATING SCALE | Baseline and post treatment after six weeks | 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain |
| Primary | UNIVERSAL GONIOMETER | Baseline and post treatment after six weeks | Cervical range of motion (ROM) will be assessed using a universal goniometer in sagittal, frontal, and transverse planes. Measurements will be taken in sitting with the thoracic spine stabilized, except rotation (supine), using anatomical landmarks (tragus, occiput, acromion, and C7). Three trials per direction will be averaged with 30-second rest intervals |
| Primary | CRANIOVERTEBRAL ANGLE (CVA) - PHOTOGRAPHIC ANALYSIS | Baseline and post treatment after six weeks | Head and neck posture will be assessed using standardised photographic methods consistent with those described in the reference study.(1) The tragus, pogonion, eye corner, and acromion process are anatomical features that will be delineated at C7. A digital camera will be placed three meters away from the subject at shoulder height, and image analysis software will be used to determine the CVA. |
| Primary | NECK DISABILITY INDEX (NDI) | Baseline and post treatment after six weeks | 0-8% indicates no disability, 10-28% indicates mild disability, 30-48% indicates moderate impairment, 50-64% indicates severe disability, and ≥65% indicates complete disability. The total scores range from 0 to 50 and are converted to percentages. |
| Primary | ANEROID SPHYGMOMANOMETER | Baseline and post treatment after six weeks | To simplify and track craniocervical flexion exercises for deep cervical flexor muscle training, a modified aneroid sphygmomanometer is employed as a pressure biofeedback tool. The sphygmomanometer\'s inflatable bladder was placed under the cervical lordosis and inflated to a baseline pressure of 20 mmHg. There is evidence that the Craniocervical Flexion Test (CCFT) has excellent reliability and acceptable validity when using a modified aneroid sphygmomanometer. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892131
GET https://conductscience.org/api/trials/v1/NCT07892131/registered